← back to search

Rasmus Leistner

Humboldt-Universität zu Berlin · DE
Area of research
Infectious Diseases · Molecular Medicine
Research interest
Research interests include Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance, Antimicrobial Resistance in Staphylococcus, and Nosocomial Infections in ICU.
h-index
27
citations
2,140
works
115
NIH funding
primary concept
email

Recent publications

Can probiotics trigger a paradigm shift for cleaning healthcare environments? A narrative review
Antimicrobial Resistance and Infection Control 2024cited by 13position: middledoi
Environmental cleaning to prevent hospital-acquired infections on non-intensive care units: a pragmatic, single-centre, cluster randomized controlled, crossover trial comparing soap-based, disinfection and probiotic cleaning
EClinicalMedicine 2023cited by 43position: firstdoi
Panton-Valentine leukocidin–induced neutrophil extracellular traps lack antimicrobial activity and are readily induced in patients with recurrent PVL + - <i>Staphylococcus aureus</i> infections
Journal of Leukocyte Biology 2023cited by 9position: middledoi
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
Critical Care 2022cited by 64position: firstdoi
Comparative analysis of surface sanitization protocols on the bacterial community structures in the hospital environment
Clinical Microbiology and Infection 2022cited by 42position: lastdoi
Skin infections due to Panton-Valentine leucocidin–producing S. aureus
Deutsches Ärzteblatt international 2022cited by 16position: firstdoi
Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis—authors’ response
Journal of Antimicrobial Chemotherapy 2022cited by 3position: lastdoi
Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis
Journal of Antimicrobial Chemotherapy 2021cited by 28position: lastdoi
Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus—Cost effectiveness of outpatient treatment
PLoS ONE 2021cited by 8position: lastdoi
Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae
Clinical Microbiology and Infection 2019cited by 63position: lastdoi
Admission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospital
PLoS ONE 2018cited by 22position: middledoi
Corrigendum to ‘Panton-Valentine Leucocidin (PVL) Staphylococcus aureus a position statement from the International Society of Chemotherapy’ [International Journal of Antimicrobial Agents 51/1 (2018) 16-25]
International Journal of Antimicrobial Agents 2018cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Petra Gastmeier · Charité - Universitätsmedizin Berlin8 papers (2018–2024)Miriam Stegemann · Charité - Universitätsmedizin Berlin4 papers (2021–2023)Axel Kola · German Center for Infection Research3 papers (2018–2021)Renate Krüger · MSB Medical School Berlin3 papers (2021–2023)Luisa A. Denkel · Humboldt-Universität zu Berlin3 papers (2018–2024)Leif G. Hanitsch · Berlin Institute of Health at Charité - Universitätsmedizin Berlin3 papers (2021–2023)Frank Schwab · Hospital for Special Surgery3 papers (2018–2023)Gregor Zakonsky · Charité - Universitätsmedizin Berlin2 papers (2022–2023)Friederike Maechler · Freie Universität Berlin2 papers (2019–2022)P. Bischoff · World Health Organization2 papers (2021–2022)Andreas K. Lindner · Humboldt-Universität zu Berlin2 papers (2022–2023)Štefan Schwarz · Iowa State University2 papers (2021–2022)Antina Lübke‐Becker · Freie Universität Berlin2 papers (2021–2022)Carolin Hackmann · Robert Koch Institute2 papers (2021–2022)Marc-Nicolas Rentinck · Humboldt-Universität zu Berlin1 papers (2021–2021)J. O. Schröder · Humboldt-Universität zu Berlin1 papers (2023–2023)Nayana Märtin · Humboldt-Universität zu Berlin1 papers (2018–2018)Arturo Zychlinsky · Max Planck Institute for Infection Biology1 papers (2023–2023)Michael Pietsch · Johannes Gutenberg University Mainz1 papers (2019–2019) · 1 papers (2022–2022)